News
CARL
14.41
-15.19%
-2.58
Carlsmed Announces U.S. Commercial Launch Of Aprevo Technology Platform For Cervical Fusion Surgeries
Benzinga · 2d ago
Carlsmed announces U.S. launch of its aprevo Technology Platform
TipRanks · 2d ago
Carlsmed Launches aprevo Technology Platform for Cervical Fusion Surgeries in U.S
Reuters · 2d ago
Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting
Barchart · 2d ago
Weekly Report: what happened at CARL last week (1124-1128)?
Weekly Report · 4d ago
Carlsmed: Back To Where We Started
Seeking Alpha · 6d ago
Weekly Report: what happened at CARL last week (1117-1121)?
Weekly Report · 11/24 09:08
Carlsmed Inc. to Present at Piper Sandler Healthcare Conference
Reuters · 11/19 21:01
Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference
Barchart · 11/19 15:01
Carlsmed, Inc. (CARL) Gets a Buy from Goldman Sachs
TipRanks · 11/18 07:45
Weekly Report: what happened at CARL last week (1110-1114)?
Weekly Report · 11/17 09:07
Weekly Report: what happened at CARL last week (1103-1107)?
Weekly Report · 11/10 09:07
Analysts Offer Insights on Healthcare Companies: Carlsmed, Inc. (CARL), Brookdale Senior Living (BKD) and Eton Pharmaceuticals (ETON)
TipRanks · 11/07 16:40
Carlsmed Price Target Raised to $20.00/Share From $18.00 by Truist Securities
Dow Jones · 11/07 15:59
Truist Securities Reiterates Buy on Carlsmed, Raises Price Target to $20
Benzinga · 11/07 15:49
Carlsmed, Inc. (CARL) Receives a Buy from Truist Financial
TipRanks · 11/07 13:26
Carlsmed price target raised to $24 from $21 at BTIG
TipRanks · 11/07 12:20
CARLSMED INC <CARL.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $20 FROM $18
Reuters · 11/07 12:15
Carlsmed Is Maintained at Buy by BTIG
Dow Jones · 11/07 09:39
Carlsmed Price Target Raised to $24.00/Share From $21.00 by BTIG
Dow Jones · 11/07 09:39
More
Webull provides a variety of real-time CARL stock news. You can receive the latest news about CARLSMED INC through multiple platforms. This information may help you make smarter investment decisions.
About CARL
Carlsmed, Inc. is a commercial-stage medical technology company providing AI-enabled personalized spine surgery solutions. Its aprevo technology platform offers solutions for the entire surgical workflow, including pre-operative AI-enabled, surgical planning; intra-operative advanced visualization to support precision placement of aprevo interbody implants, and post-operative data collection and insights intended to improve the digital surgical planning process. Its pre-operative planning software utilizes standard-of-care diagnostic imaging and AI-enabled algorithms to develop personalized digital surgical plans and to design aprevo interbody implants for each patient's pathology and vertebral bone topography. Additionally, the aprevo technology platform supports the collection of real-world, post-operative data to inform its digital surgical planning process. Its platform is commercially available in the United States and is indicated for use in lumbar interbody fusion procedures.